시장보고서
상품코드
1889391

세계의 유전자 도입 기술 시장 보고서(2025년)

Gene Transfer Technologies Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 유전자 도입 기술 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 39억 7,000만 달러에서 2025년에는 45억 4,000만 달러로, CAGR 14.5%로 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 유전자 변형 연구에 대한 수요 증가, 맞춤형 의료에 대한 관심 증가, 생명 공학 연구에 대한 정부 자금 증가, 유전자 치료 임상시험 확대, 학술 및 산업계의 협력 강화와 관련이 있습니다.

유전자 도입 기술 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 77억 달러에 달하고 CAGR은 14.1%가 될 전망입니다. 예측기간의 성장은 첨단 유전자 전달 시스템의 채용 확대, 유전자 공학 및 합성 생물학에 대한 투자 증가, 희귀질환 치료에 응용 확대, 바이오 의약품 연구 개발 활동의 확대, 유전자 기반 요법에 대한 규제면의 지원 강화에 의해 견인될 전망입니다. 예측기간의 주요 동향으로는 유전자 편집 툴의 기술적 진보, 바이러스성 및 비바이러스성 벡터의 지속적인 혁신, 유전자 전달 플랫폼의 연구개발 증가, 차세대 유전자 도입 시스템의 개발, 정밀 유전공학 기술의 진보 등을 들 수 있습니다.

유전자 질환의 유병률 상승이 유전자 도입 기술 시장의 성장을 견인할 것으로 예측됩니다. 유전자 질환은 정상적인 생물학적 기능을 손상시키는 하나 이상의 유전자 또는 염색체의 변화에 기인합니다. 유병률 증가의 주요 요인은 진단 및 보고 체제의 개선, 고령화 사회의 진전, 임상 케어의 향상에 의한 이환 유아의 생존율 상승에 있습니다. 유전자 도입 기술은 결함이 있는 유전자의 표적화 전달 및 수정을 가능하게 하고, 유전자 치료, 정밀 치료 및 고급 연구 능력의 개발을 지원합니다. 예를 들어, 2025년 2월에 세계보건기구(WHO)가 보고한 바에 따르면, 세계 3억명 이상이 희소질환을 갖고 생활하고 있으며, 그 약 70%는 소아기에 발병하고 있습니다. 이 증가 경향이 유전자 도입 기술에 대한 수요를 촉진하고 있습니다.

유전자 도입 기술 시장의 기업은 세포 및 유전자 치료의 개발 가속, 확장성의 향상, 규제 준수의 확보를 목적으로 첨단 제조 플랫폼과 통합형 위탁 개발 제조 기관(CDMO) 서비스에 대한 투자를 추진하고 있습니다. 통합 CDMO 서비스는 제품 개발, 공정 최적화 및 대규모 제조를 단일 공급자 내에서 통합하여 생산 효율성과 시장 출시 시간을 단축합니다. 예를 들어, 2025년 10월에는 미국에 거점을 둔 바이오 의약품 CDMO인 AGC Biologics가 플라스미드 DNA, 바이러스 벡터, 세포요법에 있어서의 엔드 투 엔드의 개발 및 제조 능력을 강화하기 위해 전용 세포 및 유전자 치료 사업 부문을 시작했습니다. 이 이니셔티브는 공정 효율성 향상, 임상 단계에서 상업 규모로의 전환을 간소화하고 세계 유전 도입 요법의 혁신 지원을 목표로 합니다.

자주 묻는 질문

  • 유전자 도입 기술 시장 규모는 어떻게 변화하고 있나요?
  • 유전자 도입 기술 시장의 성장을 이끄는 주요 요인은 무엇인가요?
  • 유전자 질환의 유병률 상승이 유전자 도입 기술 시장에 미치는 영향은 무엇인가요?
  • 유전자 도입 기술 시장에서 기업들이 추진하고 있는 주요 전략은 무엇인가요?
  • 유전자 도입 기술 시장의 주요 기업은 어디인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 유전자 도입 기술 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 이용 산업의 분석
  • 세계의 유전자 도입 기술 시장 : 성장률 분석
  • 세계의 유전자 도입 기술 시장 실적 : 규모와 성장, 2019-2024년
  • 세계의 유전자 도입 기술 시장 예측 : 규모와 성장, 2024-2029년, 2034F
  • 세계의 유전자 도입 기술 : 총 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 유전자 도입 기술 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 시약, 키트 및 분석
  • 소모품
  • 기기
  • 기타 제품
  • 세계의 유전자 도입 기술 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 바이러스
  • 레트로바이러스
  • 아데노바이러스
  • 아데노 관련 바이러스
  • 비바이러스성
  • 전기천공법
  • 유전자암
  • 세계의 유전자 도입 기술 시장 : 방법별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • In vivo
  • Ex Vivo
  • In vitro
  • 세계의 유전자 도입 기술 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 유전자 치료
  • 맞춤형 의료
  • 재생 의료
  • 백신 개발
  • 세계의 유전자 도입 기술 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 학술연구기관
  • 바이오의약품기업
  • 수탁연구기관
  • 세계의 유전자 도입 기술 시장 : 시약, 키트 및 분석 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 데옥시리보 핵산 시약
  • 리보 핵산 시약
  • 단백질 분석 키트
  • 세포 형질감염 키트
  • 유전자 발현 분석 키트
  • 리포터 유전자 분석
  • 세계의 유전자 도입 기술 시장 : 소모품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 배양 배지
  • 완충액 및 용액
  • 마이크로플레이트
  • 피펫 팁
  • 튜브 및 바이알
  • 필터 및 막
  • 세계의 유전자 도입 기술 시장 : 기기 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 트랜스펙션 시스템
  • 전기천공장치
  • 유전자총
  • 세포분석장치
  • 마이크로 피펫팅 시스템
  • 원심분리기
  • 세계의 유전자 도입 기술 시장 : 기타 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 세포주
  • 플라스미드 DNA
  • 바이러스 벡터
  • 나노입자
  • 마이크로플루이딕스 장치
  • 유전자 마커

제7장 지역별/국가별 분석

  • 세계의 유전자 도입 기술 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 세계의 유전자 도입 기술 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 유전자 도입 기술 시장 : 경쟁 구도
  • 유전자 도입 기술 시장 : 기업 프로파일
    • Thermo Fisher Scientific : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Evonik Industries : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Agilent Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

  • Charles River Laboratories
  • Sartorius AG
  • Bio-Techne Corporation
  • Takara Bio Inc.
  • Aldevron
  • Regenxbio Inc.
  • CureVac AG
  • OriGene Technologies
  • Precision NanoSystems
  • 4D Molecular Therapeutics
  • Synthego Corporation
  • Addgene
  • Acuitas Therapeutics
  • Transposagen Biopharmaceuticals
  • Vigene Biosciences

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • 유전자 도입 기술 시장(2029년) : 새로운 기회를 제공하는 국가
  • 유전자 도입 기술 시장(2029년) : 새로운 기회를 제공하는 부문
  • 유전자 도입 기술 시장(2029년) : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제36장 부록

JHS

Gene transfer technologies refer to advanced techniques used to introduce foreign genetic material into cells to modify or regulate their genetic composition. These technologies are essential in developing gene therapies, conducting genetic research, and producing recombinant proteins. By enabling precise genetic alterations, they support the treatment of inherited disorders and the progress of personalized medicine.

The key products in gene transfer technologies include reagents, kits, and assays, consumables, instruments, and others. Reagents, kits, and assays refer to essential tools used to facilitate and monitor the gene transfer process by enabling the effective delivery and expression of genetic material in target cells. Various modes include viral methods such as retrovirus, adenovirus, and adeno-associated virus, as well as non-viral approaches like electroporation and gene gun techniques. The key methods include in vivo, ex vivo, and in vitro. Major applications include gene therapy, personalized medicine, regenerative medicine, and vaccine development, with primary end users such as academic and research institutes, biopharmaceutical companies, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The gene transfer technologies market research report is one of a series of new reports from The Business Research Company that provides gene transfer technologies market statistics, including the gene transfer technologies industry global market size, regional shares, competitors with the gene transfer technologies market share, detailed gene transfer technologies market segments, market trends, and opportunities, and any further data you may need to thrive in the gene transfer technologies industry. This gene transfer technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gene transfer technologies market size has grown rapidly in recent years. It will grow from $3.97 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be linked to increasing demand for genetic modification research, a growing focus on personalized medicine, rising government funding for biotechnology research, expansion of gene therapy clinical trials, and increasing academic and industry collaborations.

The gene transfer technologies market size is expected to see rapid growth in the next few years. It will grow to $7.70 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be driven by growing adoption of advanced gene delivery systems, rising investment in genetic engineering and synthetic biology, increasing applications in rare disease treatment, expansion of biopharmaceutical R&D activities, and growing regulatory support for gene-based therapies. Major trends in the forecast period include technological advancements in gene editing tools, continuous innovations in viral and non-viral vectors, increasing research and development in gene delivery platforms, the development of next-generation gene transfer systems, and advancements in precision genetic engineering techniques.

The rising prevalence of genetic disorders is expected to drive the growth of the gene transfer technologies market. Genetic disorders are caused by changes in one or more genes or chromosomes that impair normal biological functions. Their increasing prevalence is largely due to improved diagnosis and reporting, aging populations, and higher survival rates of affected infants resulting from better clinical care. Gene transfer technologies enable the targeted delivery and correction of faulty genes, supporting the development of gene therapies, precision treatments, and advanced research capabilities. For instance, in February 2025, the World Health Organization reported that over 300 million people globally live with rare diseases, approximately 70% of which originate in childhood. This rising prevalence is thus fueling demand for gene transfer technologies.

Companies in the gene transfer technologies market are investing in advanced manufacturing platforms and integrated contract development and manufacturing organization (CDMO) services to accelerate cell and gene therapy development, improve scalability, and ensure regulatory compliance. Integrated CDMO services combine product development, process optimization, and large-scale manufacturing within a single provider, streamlining production and reducing time-to-market. For example, in October 2025, AGC Biologics, a US-based biopharmaceutical CDMO, launched a dedicated Cell and Gene Therapy Business Division to strengthen its end-to-end development and manufacturing capabilities for plasmid DNA, viral vectors, and cell therapies. This initiative aims to enhance process efficiency, streamline clinical-to-commercial scale transition, and support innovation in gene transfer therapies worldwide.

In July 2024, Genezen, a US-based CDMO, acquired uniQure's commercial gene therapy operations for an undisclosed amount. Through this acquisition, Genezen aims to expand its commercial gene therapy capabilities and accelerate market access for advanced therapies. UniQure is a Netherlands-based biopharmaceutical company focused on developing and commercializing gene therapies for serious genetic diseases.

Major companies operating in the gene transfer technologies market are Thermo Fisher Scientific, Merck KGaA, Evonik Industries, Lonza Group AG, Agilent Technologies Inc., Charles River Laboratories, Sartorius AG, Bio-Techne Corporation, Takara Bio Inc., Aldevron, Regenxbio Inc., CureVac AG, OriGene Technologies, Precision NanoSystems, 4D Molecular Therapeutics, Synthego Corporation, Addgene, Acuitas Therapeutics, Transposagen Biopharmaceuticals, Vigene Biosciences.

North America was the largest region in the gene transfer technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene transfer technologies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene transfer technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene transfer technologies market consists of revenues earned by entities by providing services such as cell line development services, regulatory and compliance support services, and custom assay development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene transfer technologies market also includes sales of electroporation devices, microinjection systems, cell culture media, and bioreactors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Transfer Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene transfer technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene transfer technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene transfer technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents, Kits, And Assays; Consumables; Instruments; Other Products
  • 2) By Mode: Viral; Retrovirus; Adenovirus; Adeno-Associated Virus; Non-Viral; Electroporation; Gene Gun
  • 3) By Method: In Vivo; Ex Vivo; In Vitro
  • 4) By Applications: Gene Therapy; Personalized Medicine; Regenerative Medicine; Vaccines Development
  • 5) By End User: Academic And Research Institutes; Biopharmaceutical Companies; Contract Research Organizations
  • Subsegments:
  • 1) By Reagents, Kits, And Assays: Deoxyribonucleic Acid Reagents; Ribonucleic Acid Reagents; Protein Assay Kits; Cell Transfection Kits; Gene Expression Assay Kits; Reporter Gene Assays
  • 2) By Consumables: Culture Media; Buffers And Solutions; Microplates; Pipette Tips; Tubes And Vials; Filters And Membranes
  • 3) By Instruments: Transfection Systems; Electroporators; Gene Guns; Cell Analyzers; Micropipetting Systems; Centrifuges
  • 4) By Other Products: Cell Lines; Plasmid DNA; Viral Vectors; Nanoparticles; Microfluidic Devices; Genetic Markers
  • Companies Mentioned: Thermo Fisher Scientific; Merck KGaA; Evonik Industries; Lonza Group AG; Agilent Technologies Inc.; Charles River Laboratories; Sartorius AG; Bio-Techne Corporation; Takara Bio Inc.; Aldevron; Regenxbio Inc.; CureVac AG; OriGene Technologies; Precision NanoSystems; 4D Molecular Therapeutics; Synthego Corporation; Addgene; Acuitas Therapeutics; Transposagen Biopharmaceuticals; Vigene Biosciences.
  • Countries:

Table of Contents

1. Executive Summary

2. Gene Transfer Technologies Market Characteristics

3. Gene Transfer Technologies Market Trends And Strategies

4. Gene Transfer Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gene Transfer Technologies Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Gene Transfer Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Gene Transfer Technologies Market Growth Rate Analysis
  • 5.4. Global Gene Transfer Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Gene Transfer Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Gene Transfer Technologies Total Addressable Market (TAM)

6. Gene Transfer Technologies Market Segmentation

  • 6.1. Global Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents, Kits, And Assays
  • Consumables
  • Instruments
  • Other Products
  • 6.2. Global Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Viral
  • Retrovirus
  • Adenovirus
  • Adeno-Associated Virus
  • Non-viral
  • Electroporation
  • Gene Gun
  • 6.3. Global Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Vivo
  • Ex Vivo
  • In Vitro
  • 6.4. Global Gene Transfer Technologies Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Therapy
  • Personalized Medicine
  • Regenerative Medicine
  • Vaccines Development
  • 6.5. Global Gene Transfer Technologies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Biopharmaceutical Companies
  • Contract Research Organizations
  • 6.6. Global Gene Transfer Technologies Market, Sub-Segmentation Of Reagents, Kits, And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid Reagents
  • Ribonucleic Acid Reagents
  • Protein Assay Kits
  • Cell Transfection Kits
  • Gene Expression Assay Kits
  • Reporter Gene Assays
  • 6.7. Global Gene Transfer Technologies Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture Media
  • Buffers And Solutions
  • Microplates
  • Pipette Tips
  • Tubes And Vials
  • Filters And Membranes
  • 6.8. Global Gene Transfer Technologies Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transfection Systems
  • Electroporators
  • Gene Guns
  • Cell Analyzers
  • Micropipetting Systems
  • Centrifuges
  • 6.9. Global Gene Transfer Technologies Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Lines
  • Plasmid DNA
  • Viral Vectors
  • Nanoparticles
  • Microfluidic Devices
  • Genetic Markers

7. Gene Transfer Technologies Market Regional And Country Analysis

  • 7.1. Global Gene Transfer Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Gene Transfer Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Transfer Technologies Market

  • 8.1. Asia-Pacific Gene Transfer Technologies Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Transfer Technologies Market

  • 9.1. China Gene Transfer Technologies Market Overview
  • 9.2. China Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Transfer Technologies Market

  • 10.1. India Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Transfer Technologies Market

  • 11.1. Japan Gene Transfer Technologies Market Overview
  • 11.2. Japan Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Transfer Technologies Market

  • 12.1. Australia Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Transfer Technologies Market

  • 13.1. Indonesia Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Transfer Technologies Market

  • 14.1. South Korea Gene Transfer Technologies Market Overview
  • 14.2. South Korea Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Transfer Technologies Market

  • 15.1. Western Europe Gene Transfer Technologies Market Overview
  • 15.2. Western Europe Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Transfer Technologies Market

  • 16.1. UK Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Transfer Technologies Market

  • 17.1. Germany Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Transfer Technologies Market

  • 18.1. France Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Transfer Technologies Market

  • 19.1. Italy Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Transfer Technologies Market

  • 20.1. Spain Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Transfer Technologies Market

  • 21.1. Eastern Europe Gene Transfer Technologies Market Overview
  • 21.2. Eastern Europe Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Transfer Technologies Market

  • 22.1. Russia Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Transfer Technologies Market

  • 23.1. North America Gene Transfer Technologies Market Overview
  • 23.2. North America Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Transfer Technologies Market

  • 24.1. USA Gene Transfer Technologies Market Overview
  • 24.2. USA Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Transfer Technologies Market

  • 25.1. Canada Gene Transfer Technologies Market Overview
  • 25.2. Canada Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Transfer Technologies Market

  • 26.1. South America Gene Transfer Technologies Market Overview
  • 26.2. South America Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Transfer Technologies Market

  • 27.1. Brazil Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Transfer Technologies Market

  • 28.1. Middle East Gene Transfer Technologies Market Overview
  • 28.2. Middle East Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Transfer Technologies Market

  • 29.1. Africa Gene Transfer Technologies Market Overview
  • 29.2. Africa Gene Transfer Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Gene Transfer Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Gene Transfer Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Transfer Technologies Market Competitive Landscape And Company Profiles

  • 30.1. Gene Transfer Technologies Market Competitive Landscape
  • 30.2. Gene Transfer Technologies Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Evonik Industries Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Transfer Technologies Market Other Major And Innovative Companies

  • 31.1. Charles River Laboratories
  • 31.2. Sartorius AG
  • 31.3. Bio-Techne Corporation
  • 31.4. Takara Bio Inc.
  • 31.5. Aldevron
  • 31.6. Regenxbio Inc.
  • 31.7. CureVac AG
  • 31.8. OriGene Technologies
  • 31.9. Precision NanoSystems
  • 31.10. 4D Molecular Therapeutics
  • 31.11. Synthego Corporation
  • 31.12. Addgene
  • 31.13. Acuitas Therapeutics
  • 31.14. Transposagen Biopharmaceuticals
  • 31.15. Vigene Biosciences

32. Global Gene Transfer Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Transfer Technologies Market

34. Recent Developments In The Gene Transfer Technologies Market

35. Gene Transfer Technologies Market High Potential Countries, Segments and Strategies

  • 35.1 Gene Transfer Technologies Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Gene Transfer Technologies Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Gene Transfer Technologies Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제